Imaging in multiple sclerosis

Neurology in Practice

Volumn 76, Issue 3, 2005, Pages

  Trip, S A ^a   Miller, David H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB;

BRAIN INJURY; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; LEUKODYSTROPHY; MICROVASCULAR ISCHEMIA; MULTIPLE SCLEROSIS; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; VASCULITIS; WHITE MATTER;

BRAIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; OPTIC NERVE; SENSITIVITY AND SPECIFICITY;

EID: 24144433019     PISSN: 14737086     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.073213     Document Type: Review

References (10)

1. Pretorius PM, Quaghebeur G. The role of MRI in the diagnosis of MS. Clin Radiol 2003;58:434-8. A useful pictorial review with 35 MRI images which includes the differential radiological diagnosis of MS.
2. Symms M, Jager HR, Schmierer K, et al. A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry 2004;75:1235-44. From the "Neuroscience for Neurologists" series. Reviews non-conventional MRI techniques as applied to neurological diseases including MS.
3. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 2005;4:341-8. Part 2 of a comprehensive review of CIS including findings from non-conventional MRI.
4. Lycklama G, Thompson A, Filippi M, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003;2:555-62. A comprehensive review of all aspects of spinal cord imaging in MS.
5. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12.
6. Poser CM, Paty DM, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
7. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
8. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21:702-6.
9. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7. The current diagnostic criteria for MS.
10. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neuro; 2005;4:281-8. Part 1 of a comprehensive review of CIS including the role of conventional MRI in diagnosis and predicting prognosis.